Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Sprecher

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Journal of Clinical Investigation|September 1, 1991
Chylomicron-retinyl palmitate clearance in type I hyperlipidemic familiesD L Sprecher, S L Knauer, D M Black, et al.
Journal of Lipid Research|June 1, 1992
Trp64----nonsense mutation in the lipoprotein lipase geneD L Sprecher, J Kobayashi, M Rymaszewski, et al.
Biochimica Et Biophysica Acta|June 1, 2000
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathwayR G Salomon, E Batyreva, K Kaur, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Annals of Internal Medicine|October 1, 1993
Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat dietsD L Sprecher, B V Harris, A C Goldberg, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Journal of Clinical Investigation|September 1, 1991
Chylomicron-retinyl palmitate clearance in type I hyperlipidemic familiesD L Sprecher, S L Knauer, D M Black, et al.
Journal of Lipid Research|June 1, 1992
Trp64----nonsense mutation in the lipoprotein lipase geneD L Sprecher, J Kobayashi, M Rymaszewski, et al.
Biochimica Et Biophysica Acta|June 1, 2000
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathwayR G Salomon, E Batyreva, K Kaur, et al.
The American Journal of Cardiology|April 15, 1986
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, L A Zech, et al.
Clinical Pharmacology and Therapeutics|October 1, 1984
Neomycin and plasma lipoproteins in type II hyperlipoproteinemiaJ M Hoeg, E J Schaefer, C A Romano, et al.
Circulation|December 1, 1984
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacinJ M Hoeg, M B Maher, E Bou, et al.
Annals of Internal Medicine|October 1, 1993
Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat dietsD L Sprecher, B V Harris, A C Goldberg, et al.
Pageof 8